Mouse models in tendon and ligament research

Advances in Experimental Medicine and Biology

Volumn 802, Issue , 2014, Pages 201-230

  Mienaltowski, Michael J ^a   Birk, David E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

cho mouse model; Chondrodysplasia; Collagen XIV; Crtap; Fibril forming collagens; Mouse model for mutated Col12a1; oim mouse model; or Lepre null mice; Osteogenesis Imperfecta; Ppib; Scleraxis transgenic model mice

Indexed keywords

CELL MEMBRANE PROTEIN; COLLAGEN FIBRIL; COLLAGEN TYPE 1; COLLAGEN TYPE 11; COLLAGEN TYPE 12; COLLAGEN TYPE 14; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 5; CYCLOPHILIN B; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 2; FIBRILLIN; GROWTH DIFFERENTIATION FACTOR; HERMES ANTIGEN; MEMBRANE PROTEIN; PROTEIN FACIT; PROTEIN MOHAWK; PROTEIN SCLERAXIS; PROTEIN SLRP; PROTEIN TENOMODULIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL SURFACE RECEPTOR; COLLAGEN; COLLAGEN TYPE 6; FIBRIL ASSOCIATED COLLAGEN WITH INTERRUPTED TRIPLE HELIX; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROTEOGLYCAN; SCLERAXIS; SMALL LEUCINE RICH PROTEOGLYCAN; TENOMODULIN;

ARTICLE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; EHLERS DANLOS SYNDROME; EXTRACELLULAR MATRIX; GENE CONTROL; GENETIC REGULATION; LIGAMENT DISEASE; MOUSE MODEL; NONHUMAN; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; PROTEIN PROCESSING; TENDON DISEASE; TISSUE REGENERATION; TISSUE REPAIR; TRANSGENIC MOUSE; COLLAGEN FIBER; COLLAGEN FIBRIL; GENE; HUMAN; LIGAMENT; MOHAWK GENE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TENDON;

EID: 84934441462     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-7-7893-1_13     Document Type: Article

References (153)

1. Birk DE, Mayne R (1997) Localization of collagen types I, III and V during tendon Development. Changes in collagen types I and III are correlated with changes in fi bril diameter. Eur J Cell Biol 72(4):352-361
2. Riechert K, Labs K, Lindenhayn K, Sinha P (2001) Semiquantitative analysis of types I and III collagen from tendons and ligaments in a rabbit model. J Orthop Sci 6(1):68-74
3. Fukuta S, Oyama M, Kavalkovich K, Fu FH, Niyibizi C (1998) Identifi cation of types II, IX and X collagens at the insertion site of the bovine Achilles tendon. Matrix Biol 17(1):65-73
4. Milz S, Jakob J, Buttner A, Tischer T, Putz R, Benjamin M (2008) The structure of the coracoacromial ligament: Fi brocartilage differentiation Does not necessarily mean pathology. Scand J Med Sci Sports 18(1):16-22
5. Barker DD, Wu H, Hartung S, Breindl M, Jaenisch R (1991) Retrovirus-induced insertional mutagenesis: Mechanism of collagen mutation in Mov13 mice. Mol Cell Biol 11(10):5154-5163
6. Hartung S, Jaenisch R, Breindl M (1986) Retrovirus insertion inactivates mouse alpha 1(I) collagen gene by blocking initiation of transcription. Nature 320(6060):365-367
7. Jaenisch R, Harbers K, Schnieke A, Lohler J, Chumakov I, Jahner D, Grotkopp D, Hoffmann E (1983) Germline integration of moloney murine leukemia virus at the Mov13 locus leads to recessive lethal mutation and early embryonic death. Cell 32(1):209-216
8. Chipman SD, Sweet HO, McBride DJ Jr, Davisson MT, Marks SC Jr, Shuldiner AR, Wenstrup RJ, Rowe DW, Shapiro JR (1993) Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: A model of human osteogenesis imperfecta. Proc Natl Acad Sci U S A 90(5):1701-1705
9. Aszodi A, Chan D, Hunziker E, Bateman JF, Fassler R (1998) Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. J Cell Biol 143(5):1399-1412
10. Aszodi A, Hunziker EB, Olsen BR, Fassler R (2001) The role of collagen II and cartilage fi bril-Associated molecules in skeletal development. Osteoarthr Cartilage 9(Suppl A):S150-S159
11. Rani PU, Stringa E, Dharmavaram R, Chatterjee D, Tuan RS, Khillan JS (1999) Restoration of normal bone development by human homologue of collagen type II (COL2A1) gene in Col2a1 null mice. Dev Dyn 214(1):26-33
12. Cooper TK, Zhong Q, Krawczyk M, Tae HJ, Muller GA, Schubert R, Myers LA, Dietz HC, Talan MI, Briest W (2010) The haploinsuffi cient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome. Vet Pathol 47(6):1028-1039
13. Liu X, Wu H, Byrne M, Krane S, Jaenisch R (1997) Type III collagen is crucial for collagen I fi brillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A 94(5):1852-1856
14. Smith LB, Hadoke PW, Dyer E, Denvir MA, Brownstein D, Miller E, Nelson N, Wells S, Cheeseman M, Greenfi eld A (2011) Haploinsuffi ciency of the murine Col3a1 locus causes aortic dissection: A novel model of the vascular type of Ehlers-Danlos syndrome. Cardiovasc Res 90(1):182-190
15. Andrikopoulos K, Liu X, Keene DR, Jaenisch R, Ramirez F (1995) Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen During matrix assembly. Nat Genet 9(1):31-36
16. Lincoln J, Florer JB, Deutsch GH, Wenstrup RJ, Yutzey KE (2006) ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. Dev Dyn 235(12):3295-3305
17. Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, Birk DE (2004) Type V collagen controls the initiation of collagen fi bril assembly. J Biol Chem 279(51):53331-53337
18. Wenstrup RJ, Smith SM, Florer JB, Zhang G, Beason DP, Seegmiller RE, Soslowsky LJ, Birk DE (2011) Regulation of collagen fi bril nucleation and initial fi bril assembly involves coordinate interactions with collagens V and XI in Developing tendon. J Biol Chem 286(23):20455-20465
19. Li Y, Lacerda DA, Warman ML, Beier DR, Yoshioka H, Ninomiya Y, Oxford JT, Morris NP, Andrikopoulos K, Ramirez F et al (1995) A fi brillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell 80(3):423-430
20. Byers PH, Bonadio JF, Cohn DH, Starman BJ, Wenstrup RJ, Willing MC (1988) Osteogenesis imperfecta: The molecular basis of clinical heterogeneity. Ann N Y Acad Sci 543:117-128
21. Rohrbach M, Giunta C (2012) Recessive osteogenesis imperfecta: Clinical, radiological, and molecular fi ndings. Am J Med Genet C Semin Med Genet 160C(3):175-189
22. Gentry BA, Ferreira JA, McCambridge AJ, Brown M, Phillips CL (2010) Skeletal muscle weakness in osteogenesis imperfecta mice. Matrix Biol 29(7):638-644
23. McBride DJ Jr, Choe V, Shapiro JR, Brodsky B (1997) Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. J Mol Biol 270(2):275-284
24. Misof K, Landis WJ, Klaushofer K, Fratzl P (1997) Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J Clin Invest 100(1):40-45
25. Pfeiffer BJ, Franklin CL, Hsieh FH, Bank RA, Phillips CL (2005) Alpha 2(I) collagen Defi cient oim mice have altered biomechanical integrity, collagen content, and collagen crosslinking of their thoracic aorta. Matrix Biol 24(7):451-458
26. Bonod-Bidaud C, Roulet M, Hansen U, Elsheikh A, Malbouyres M, Ricard-Blum S, Faye C, Vaganay E, Rousselle P, Ruggiero F (2012) In vivo evidence for a bridging role of a collagen V subtype at the epidermis- dermis interface. J Invest Dermatol 132(7):1841-1849
27. Imamura Y, Scott IC, Greenspan DS (2000) The proalpha3( V) collagen chain. Complete primary structure, expression Domains in adult and developing tissues, and comparison to the structures and expression Domains of the other types V and XI procollagen chains. J Biol Chem 275(12):8749-8759
28. Malfait F, Wenstrup RJ, De Paepe A (2010) Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med 12(10):597-605
29. Symoens S, Syx D, Malfait F, Callewaert B, De Backer J, Vanakker O, Coucke P, De Paepe A (2012) Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refi ne diagnostic criteria. Hum Mutat 33(10):1485-1493
30. Wenstrup RJ, Florer JB, Cole WG, Willing MC, Birk DE (2004) Reduced type I collagen utilization: A pathogenic mechanism in COL5A1 haploinsuffi cient Ehlers-Danlos syndrome. J Cell Biochem 92(1):113-124
31. Sun M, Chen S, Adams SM, Florer JB, Liu H, Kao WW, Wenstrup RJ, Birk DE (2011) Collagen V is a dominant regulator of collagen fi brillogenesis: Dysfunctional regulation of structure and function in a corneal-stroma-specifi c Col5a1-null mouse model. J Cell Sci 124(Pt 23):4096-4105
32. Seegmiller R, Fraser FC, Sheldon H (1971) A new chondrodystrophic mutant in mice. Electron microscopy of normal and abnormal chondrogenesis. J Cell Biol 48(3):580-593
33. Tompson SW, Bacino CA, Safi na NP, Bober MB, Proud VK, Funari T, Wangler MF, Nevarez L, Ala- Kokko L, Wilcox WR, Eyre DR, Krakow D, Cohn DH (2010) Fibrochondrogenesis results from mutations in the COL11A1 type XI collagen gene. Am J Hum Genet 87(5):708-712
34. Rodriguez RR, Seegmiller RE, Stark MR, Bridgewater LC (2004) A type XI collagen mutation leads to increased degradation of type II collagen in articular cartilage. Osteoarthr Cartilage 12(4):314-320
35. Gorres KL, Raines RT (2010) Prolyl 4-hydroxylase. Crit Rev Biochem Mol Biol 45(2):106-124
36. Bruckner P, Eikenberry EF, Prockop DJ (1981) Formation of the triple helix of type I procollagen in cellulo. A kinetic model based on cis-Trans isomerization of peptide bonds. Eur J Biochem 118(3):607-613
37. Marini JC, Cabral WA, Barnes AM (2010) Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res 339(1):59-70
38. Steinmann B, Bruckner P, Superti-Furga A (1991) Cyclosporin A slows collagen triple-helix formation in vivo: Indirect evidence for a physiologic role of peptidyl-prolyl cis-Trans-isomerase. J Biol Chem 266(2):1299-1303
39. Baldridge D, Lennington J, Weis M, Homan EP, Jiang MM, Munivez E, Keene DR, Hogue WR, Pyott S, Byers PH, Krakow D, Cohn DH, Eyre DR, Lee B, Morello R (2010) Generalized connective tissue disease in Crtap-/- mouse. PLoS One 5(5):e10560
40. Chang W, Barnes AM, Cabral WA, Bodurtha JN, Marini JC (2010) Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex. Hum Mol Genet 19(2):223-234
41. Choi JW, Sutor SL, Lindquist L, Evans GL, Madden BJ, Bergen HR 3rd, Hefferan TE, Yaszemski MJ, Bram RJ (2009) Severe osteogenesis imperfecta in cyclophilin B-defi cient mice. PLoS Genet 5(12):e1000750
42. Holster T, Pakkanen O, Soininen R, Sormunen R, Nokelainen M, Kivirikko KI, Myllyharju J (2007) Loss of assembly of the main basement membrane collagen, type IV, but not fi bril-forming collagens and embryonic death in collagen prolyl 4- hydroxylase I null mice. J Biol Chem 282(4):2512-2519
43. Vranka J, Stadler HS, Bachinger HP (2009) Expression of prolyl 3-hydroxylase genes in embryonic and adult mouse tissues. Cell Struct Funct 34(2):97-104
44. Vranka JA, Pokidysheva E, Hayashi L, Zientek K, Mizuno K, Ishikawa Y, Maddox K, Tufa S, Keene DR, Klein R, Bachinger HP (2010) Prolyl 3- hydroxylase 1 null mice display abnormalities in fi brillar collagen-rich tissues such as tendons, skin, and bones. J Biol Chem 285(22):17253-17262
45. Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, HP B, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127(2):291-304
46. Ansorge HL, Meng X, Zhang G, Veit G, Sun M, Klement JF, Beason DP, Soslowsky LJ, Koch M, Birk DE (2009) Type XIV collagen regulates fi brillogenesis: Premature collagen fi bril growth and tissue dysfunction in null mice. J Biol Chem 284(13):8427-8438
47. Izu Y, Sun M, Zwolanek D, Veit G, Williams V, Cha B, Jepsen KJ, Koch M, Birk DE (2011) Type XII collagen regulates osteoblast polarity and communication During bone formation. J Cell Biol 193(6):1115-1130
48. Koch M, Bernasconi C, Chiquet M (1992) A major oligomeric fi broblast proteoglycan identifi ed as a novel large form of type-XII collagen. Eur J Biochem 207(3):847-856
49. Niyibizi C, Visconti CS, Kavalkovich K, Woo SL (1995) Collagens in an adult bovine medial collateral ligament: Immunofl uorescence localization by confocal microscopy reveals that type XIV collagen predominates at the ligament-bone junction. Matrix Biol 14(9):743-751
50. Zhang G, Young BB, Birk DE (2003) Differential expression of type XII collagen in Developing chicken metatarsal tendons. J Anat 202(5):411-420
51. Fluck M, Giraud M, Tunc V, Chiquet M (2003) Tensile stress-dependent collagen XII and fi bronectin production by fi broblasts requires separate pathways. Biochim Biophys Acta 1593(2-3):239-248
52. Nishiyama T, McDonough AM, Bruns RR, Burgeson RE (1994) Type XII and XIV collagens mediate interactions between banded collagen fi bers in vitro and may modulate extracellular matrix deformability. J Biol Chem 269(45):28193-28199
53. Jin X, Iwasa S, Okada K, Ooi A, Mitsui K, Mitsumata M (2003) Shear stress-induced collagen XII expression is associated with atherogenesis. Biochem Biophys Res Commun 308(1):152-158
54. Arai K, Nagashima Y, Takemoto T, Nishiyama T (2008) Mechanical strain increases expression of type XII collagen in murine osteoblastic MC3T3-E1 cells. Cell Struct Funct 33(2):203-210
55. Chiquet M, Mumenthaler U, Wittwer M, Jin W, Koch M (1998) The chick and human collagen alpha1(XII) gene promoter - Activity of highly conserved regions around the fi rst exon and in the fi rst intron. Eur J Biochem 257(2):362-371
56. Reichenberger E, Baur S, Sukotjo C, Olsen BR, Karimbux NY, Nishimura I (2000) Collagen XII mutation Disrupts matrix structure of periodontal ligament and skin. J Dent Res 79(12):1962-1968
57. Ameye L, Young MF (2002) Mice defi cient in small leucine-rich proteoglycans: Novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12(9):107R-116R
58. Chakravarti S (2002) Functions of lumican and fi bromodulin: Lessons from knockout mice. Glycoconj J 19(4-5):287-293
59. Chen S, Birk DE (2013) The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. FEBS J 280(10):2120-2137. PMC#3651807
60. Kalamajski S, Oldberg A (2010) The role of small leucine-rich proteoglycans in collagen fi brillogenesis. Matrix Biol 29(4):248-253
61. Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE (2000) Differential expression of lumican and fi bromodulin regulate collagen fi brillogenesis in Developing mouse tendons. J Cell Biol 151(4):779-788
62. Zhang G, Young BB, Ezura Y, Favata M, Soslowsky LJ, Chakravarti S, Birk DE (2005) Development of tendon structure and function: Regulation of collagen fi brillogenesis. J Musculoskelet Neuronal Interact 5(1):5-21
63. Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, Oldberg A, Birk DE, Chakravarti S (2002) A syndrome of joint laxity and impaired tendon integrity in lumican- And fi bromodulin-defi cient mice. J Biol Chem 277(38):35532-35540
64. Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF (2002) Abnormal collagen fi brils in tendons of biglycan/fi bromodulin-defi cient mice lead to gait impairment, ectopic ossifi cation, and osteoarthritis. FASEB J 16(7):673-680
65. Dunkman AA, Buckley MR, Mienaltowski MJ, Adams SM, Thomas SJ, Satchell L, Kumar A, Pathmanathan L, Beason DP, Iozzo RV, Birk DE, Soslowsky LJ (2013) Decorin expression is important for age-related changes in tendon structure and mechanical properties. Matrix Biol 32(1):3-13. PMC#3615887
66. Zhang G, Ezura Y, Chervoneva I, Robinson PS, Beason DP, Carine ET, Soslowsky LJ, Iozzo RV, Birk DE (2006) Decorin regulates assembly of collagen fi brils and acquisition of biomechanical properties during tendon Development. J Cell Biochem 98(6):1436-1449
67. Svensson L, Heinegard D, Oldberg A (1995) Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5. J Biol Chem 270(35):20712-20716
68. Zhang G, Chen S, Goldoni S, Calder BW, Simpson HC, Owens RT, McQuillan DJ, Young MF, Iozzo RV, Birk DE (2009) Genetic evidence for the coordinated regulation of collagen fi brillogenesis in the cornea by decorin and biglycan. J Biol Chem 284(13):8888-8897
69. Ansorge HL, Adams S, Birk DE, Soslowsky LJ (2011) Mechanical, compositional, and structural properties of the post-natal mouse Achilles tendon. Ann Biomed Eng 39(7):1904-1913
70. Young MF, Bi Y, Ameye L, Chen XD (2002) Biglycan knockout mice: New models for musculoskeletal diseases. Glycoconj J 19(4-5):257-262
71. Kilts T, Ameye L, Syed-Picard F, Ono M, Berendsen AD, Oldberg A, Heegaard AM, Bi Y, Young MF (2009) Potential roles for the small leucine-rich proteoglycans biglycan (Bgn) and fi bromodulin (Fmod) in ectopic ossifi cation of tendon induced by exercise and in rotarod performance. Scand J Med Sci Sports 19(4):536-546
72. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, Shi S, Young MF (2007) Identifi cation of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 13(10):1219-1227
73. Wadhwa S, Embree MC, Kilts T, Young MF, Ameye LG (2005) Accelerated osteoarthritis in the temporomandibular joint of biglycan/fi bromodulin Doubledefi cient mice. Osteoarthr Cartilage 13(9):817-827
74. Mienaltowski MJ, Adams SM, Birk DE (2013) Regional differences in stem cell/progenitor cell populations from the mouse Achilles tendon. Tissue Eng Part A 19(1-2):199-210. PMC#3530943
75. Svensson L, Aszodi A, Reinholt FP, Fassler R, Heinegard D, Oldberg A (1999) Fibromodulinnull mice have abnormal collagen fi brils, tissue organization, and altered lumican Deposition in tendon. J Biol Chem 274(14):9636-9647
76. Bruns RR, Press W, Engvall E, Timpl R, Gross J (1986) Type VI collagen in extracellular, 100-nm periodic fi laments and fi brils: Identifi cation by immunoelectron microscopy. J Cell Biol 103(2):393-404
77. Furthmayr H, Wiedemann H, Timpl R, Odermatt E, Engel J (1983) Electron-microscopical approach to a structural model of intima collagen. Biochem J 211(2):303-311
78. von Der Mark H, Aumailley M, Wick G, Fleischmajer R, Timpl R (1984) Immunochemistry, genuine size and tissue localization of collagen VI. Eur J Biochem 142(3):493-502
79. Kielty C, Grant ME (2002) The collagen family: Structure, assembly, and organization in the extracellular matrix. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders. Wiley- Liss, New York, pp 159-222
80. Lampe AK, Bushby KM (2005) Collagen VI related muscle disorders. J Med Genet 42(9):673-685
81. Bonaldo P, Braghetta P, Zanetti M, Piccolo S, Volpin D, Bressan GM (1998) Collagen VI defi ciency induces early onset myopathy in the mouse: An animal model for Bethlem myopathy. Hum Mol Genet 7(13):2135-2140
82. Christensen SE, Coles JM, Zelenski NA, Furman BD, Leddy HA, Zauscher S, Bonaldo P, Guilak F (2012) Altered trabecular bone structure and delayed cartilage degeneration in the knees of collagen VI null mice. PLoS One 7(3):e33379
83. Izu Y, Ansorge HL, Zhang G, Soslowsky LJ, Bonaldo P, Chu ML, Birk DE (2011) Dysfunctional tendon collagen fi brillogenesis in collagen VI null mice. Matrix Biol 30(1):53-61
84. Izu Y, Ezura Y, Mizoguchi F, Kawamata A, Nakamoto T, Nakashima K, Hayata T, Hemmi H, Bonaldo P, Noda M (2012) Type VI collagen Defi ciency induces osteopenia with distortion of osteoblastic cell morphology. Tissue Cell 44(1):1-6
85. Arteaga-Solis E, Sui-Arteaga L, Kim M, Schaffl er MB, Jepsen KJ, Pleshko N, Ramirez F (2011) Material and mechanical properties of bones defi - cient for fi brillin-1 or fi brillin-2 microfi brils. Matrix Biol 30(3):188-194
86. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM, Stetten G, Meyers DA, Francomano CA (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fi brillin gene. Nature 352(6333):337-339
87. Lee B, Godfrey M, Vitale E, Hori H, Mattei MG, Sarfarazi M, Tsipouras P, Ramirez F, Hollister DW (1991) Linkage of Marfan syndrome and a phenotypically related disorder to different fi brillin genes. Nature 352(6333):330-334
88. Ritty TM, Ditsios K, Starcher BC (2002) Distribution of the elastic fi ber and associated proteins in fl exor tendons refl ects function. Anat Rec 268(4):430-440
89. Smith KD, Vaughan-Thomas A, Spiller DG, Innes JF, Clegg PD, Comerford EJ (2011) The organisation of elastin and fi brillins 1 and 2 in the cruciate ligament complex. J Anat 218(6):600-607
90. Boregowda R, Paul E, White J, Ritty TM (2008) Bone and soft connective tissue alterations results from loss of fi brillin-2 expression. Matrix Biol 27(8):661-666
91. Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Carta L, Ono RN, Sengle G, Arteaga-Solis E, Levasseur R, Ducy P, Sakai LY, Karsenty G, Ramirez F (2010) Fibrillin-1 and -2 differentially modulate endogenous TGF-beta and BMP bioavailability during bone formation. J Cell Biol 190(6):1107-1121
92. Miller G, Neilan M, Chia R, Gheryani N, Holt N, Charbit A, Wells S, Tucci V, Lalanne Z, Denny P, Fisher EM, Cheeseman M, Askew GN, Dear TN (2010) ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fi brillin 2. PLoS One 5(2):e9137
93. Cook JR, Smaldone S, Cozzolino C, Del Solar M, Lee-Arteaga S, Nistala H, Ramirez F (2012) Generation of Fbn1 conditional null mice implicates the extracellular microfi brils in osteoprogenitor recruitment. Genesis 50(8):635-641
94. Mendias CL, Bakhurin KI, Faulkner JA (2008) Tendons of myostatin-defi cient mice are small, brittle, and hypocellular. Proc Natl Acad Sci U S A 105(1):388-393
95. Edom-Vovard F, Bonnin MA, Duprez D (2001) Misexpresison of Fgf-4 in the chick limb inhibits myogenesis by down-regulating Frek expression. Dev Biol 233(1):56-71
96. Edom-Vovard F, Schuler B, Bonnin MA, Teillet MA, Duprez D (2002) Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons. Dev Biol 247(2):351-366
97. Edom-Vovard F, Bonnin MA, Duprez D (2001) Fgf8 transcripts are located in tendons during embryonic chick limb development. Mech Dev 108(1-2):203-206
98. Galatz L, Rothermich S, VanderPloeg K, Petersen B, Sandell L, Thomopoulos S (2007) Development of the supraspinatus tendon-To-bone insertion: Localized expression of extracellular matrix and growth factor genes. J Orthop Res 25(12):1621-1628
99. Kuo CK, Peterson BC, Tuan RS (2008) Spatiotemporal protein Distribution of TGF-Bs, their receptor, and extracellular matrix molecules during embryonic tendon Development. Dev Dyn 237(5):1477-1489
100. Schweitzer R, Chyung JH, Murtaugh LC, Brent AE, Rosen V, Olson EN, Lassar A, Tabin CJ (2001) Analysis of the tendon cell fate using Scleraxis, a specifi c marker for tendons and ligaments. Development 128(19):3855-3866
101. Kobayashi M, Minagawa H, Miyakoshi N, Takahashi S, Tuoheti Y, Okada K, Shimada Y (2006) Expression of growth factors in the early phase of supraspinatus tendon healing in rabbits. J Should Elbow Surg 15(3):371-377
102. Galatz L, Sandell LJ, Rothermich SY, Das R, Mastny A, Havlioglu N, Silva MJ, Thomopoulos S (2006) Characteristics of the rat supraspinatus tendon During tendon-To-bone healing after acute injury. J Orthop Res 24(3):541-550
103. Hirose K, Kondo S, Choi HR, Mishima S, Iwata H, Ishiguro N (2004) Spontaneous healing process of a supraspinatus tear in rabbits. Arch Orthop Trauma Surg 124(6):374-377
104. Dines JS, Grande DA, Dines DM (2007) Tissue engineering and rotator cuff tendon healing. J Should Elbow Surg 16(5 Suppl):S204-S207
105. Wrgler CC, Dourte LM, Baradet TC, Williams GR, Soslowsky LJ (2007) Temporal expression of 8 growth factors in tendon-To-bone healing in a rat supraspinatus model. J Should Elbow Surg 16(5 Suppl):S198-S203
106. Crowe MJ, Doetschman T, Greenhalgh DG (2000) Delayed wound healing in immunodefi cient TGFbeta 1 knockout mice. J Invest Dermatol 115(1):3-11
107. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T (1997) Tgfbeta2 knockout mice have multiple developmental defects that are nonoverlapping with other TGFbeta knockout phenotypes. Development 124(13):2659-2670
108. Pryce BA, Watson SS, Murchison ND, Staverosky JA, Dunker N, Schweitzer R (2009) Recruitment and maintenance of tendon progenitors by TGFbeta signaling are essential for tendon formation. Development 136(8):1351-1361
109. Dunker N, Krieglstein K (2002) Tgfbeta2 -/- Tgfbeta3 -/- double knockout mice display severe midline fusion Defects and early embryonic lethality. Anat Embryol (Berl) 206(1-2):73-83
110. Dunker N, Schmitt K, Krieglstein K (2002) TGFbeta is required for programmed cell death in interdigital webs of the developing mouse limb. Mech Dev 113(2):111-120
111. Tsubone T, Moran SL, Subramaniam M, Amadio PC, Spelsberg TC, An KN (2006) Effect of TGFbeta inducible early gene defi ciency on fl exor tendon healing. J Orthop Res 24(3):569-575
112. Mikic B (2004) Multiple effects of GDF-5 defi ciency on skeletal tissues: Implications for therapeutic bioengineering. Ann Biomed Eng 32(3):466-476
113. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee S-J (1994) Limb alteration in brachypodism mice due to mutations in a new member of the TGF-beta superfamily. Nature 368(6472):639-643
114. Duke J, Elmer WA (1977) Effect of the brachypod mutation on cell adhesion and chondrogenesis in aggregates of mouse limb mesenchyme. J Embryol Exp Morphol 42:209-217
115. Mikic B, Battaglia TC, Taylor EA, Clark RT (2002) The effect of growth/differentiation factor-5 defi - ciency on femoral composition and mechanical behavior in mice. Bone 30(5):733-737
116. Daans M, Luyten FP, Lories RJ (2011) GDF5 defi - ciency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann Rheum Dis 70(1):208-213
117. Mikic B, Schalet BJ, Clark RT, Gaschen V, Hunziker E (2001) GDF-5 defi ciency in mice alters the ultrastructure, mechanical properties and composition of the Achilles tendon. J Orthop Res 19(3):365-371
118. Chhabra A, Tsou D, Clark RT, Gaschen V, Hunziker EB, Mikic B (2003) GDF-5 defi ciency in mice delays Achilles tendon healing. J Orthop Res 21(5):826-835
119. Mikic B, Rossmeier K, Bierwert L (2009) Identifi cation of a tendon phenotype in GDF6 defi - cient mice. Anat Rec (Hoboken) 292(3):396-400
120. Mikic B, Rossmeier K, Bierwert L (2009) Sexual dimorphism in the effect of GDF-6 defi ciency on murine tendon. J Orthop Res 27(12):1603-1611
121. Mikic B, Bierwert L, Tsou D (2006) Achilles tendon characterization in GDF-7 defi cient mice. J Orthop Res 24(4):831-841
122. Mikic B, Entwistle R, Rossmeier K, Bierwert L (2008) Effect of GDF-7 defi ciency on tail tendon phenotype in mice. J Orthop Res 26(6):834-839
123. Asou Y, Nifuji A, Tsuji K, Shinomiya K, Olson EN, Koopman P, Noda M (2002) Coordinated expression of scleraxis and Sox9 genes during embryonic development of tendons and cartilage. J Orthop Res 20(4):827-833
124. Cserjesi P, Brown D, Ligon KL, Lyons GE, Copeland NG, Gilbert DJ, Jenkins NA, Olson EN (1995) Scleraxis: A basic helix-loop-helix protein that prefi gures skeletal formation During mouse embryogenesis. Development 121(4):1099-1110
125. Perez AV, Perrine M, Brainard N, Vogel KG (2003) Scleraxis (Scx) directs lacZ expression in tendon of transgenic mice. Mech Dev 120(10):1153-1163
126. Brent AE, Tabin CJ (2004) FGF acts directly on the somitic tendon progenitors through the Ets transcription factors Pea3 and Erm to regulate scleraxis expression. Development 131(16):3885-3896
127. Shukunami C, Takimoto A, Oro M, Hiraki Y (2006) Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol 298(1):234-247
128. Scott A, Sampaio A, Abraham T, Duronio C, Underhill TM (2011) Scleraxis expression is coordinately regulated in a murine model of patellar tendon injury. J Orthop Res 29(2):289-296
129. Alberton P, Popov C, Pragert M, Kohler J, Shukunami C, Schieker M, Docheva D (2012) Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis. Stem Cells Dev 21(6):846-858
130. Pryce BA, Brent AE, Murchison ND, Tabin CJ, Schweitzer R (2007) Generation of transgenic tendon reporters, ScxGFP and ScxAP, using regulatory elements of the scleraxis gene. Dev Dyn 236(6):1677-1682
131. Mendias CL, Gumucio JP, Bakhurin KI, Lynch EB, Brooks SV (2012) Physiological loading of tendons induces scleraxis expression in epitenon fi broblasts. J Orthop Res 30(4):606-612
132. Wang L, Bresee CS, Jiang H, He W, Ren T, Schweitzer R, Brigande JV (2011) Scleraxis is required for differentiation of the stapedius and tensor tympani tendons of the middle ear. J Assoc Res Otolaryngol 12(4):407-421
133. Murchison ND, Price BA, Conner DA, Keene DR, Olson EN, Tabin CJ, Schweitzer R (2007) Regulation of tendon Differentiation by scleraxis distinguishes force-Transmitting tendons from muscle-Anchoring tendons. Development 134(14):2697-2708
134. Ito Y, Toriuchi N, Yoshitaka T, Ueno-Kudoh H, Sato T, Yokoyama S, Nishida K, Akimoto T, Takahashi M, Miyaki S, Asahara H (2010) The Mohawk homeobox gene is a critical regulator of tendon Differentiation. Proc Natl Acad Sci U S A 107(23):10538-10542
135. Liu W, Watson SS, Lan Y, Keene DR, Ovitt CE, Liu H, Schweitzer R, Jiang R (2010) The atypical homeodomain transcription factor Mohawk controls tendon morphogenesis. Mol Cell Biol 30(20):4797-4807
136. Becker S, Pasca G, Strumpf D, Min L, Volk T (1997) Reciprocal signaling between Drosophila epidermal muscle attachment cells and their corresponding muscles. Development 124(13):2615-2622
137. Frommer G, Vorbruggen G, Pasca G, Jacke H, Volk T (1996) Epidermal egr-like zinc fi nger protein of Drosophila participates in myotube guidance. EMBO J 15(7):1642-1649
138. Lejard V, Blais F, Guerquin MJ, Bonnet A, Bonnin MA, Havis E, Malbouyres M, Bidaud CB, Maro G, Gilardi-Hebenstreit P, Rossert J, Ruggiero F, Duprez D (2011) EGR1 and EGR2 involvement in vertebrate tendon Differentiation. J Biol Chem 286(7):5855-5867
139. Shukunami C, Oshima Y, Hiraki Y (2005) Chondromodulin-I and tenomodulin: A new class of tissue-specifi c angiogenesis inhibitors found in hypovascular connective tissues. Biochem Biophys Res Commun 333(2):299-307
140. Docheva D, Hunziker EB, Fassler R, Brandau O (2005) Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol 25(2):699-705
141. Pure E, Cuff CA (2001) A crucial role for CD44 in infl ammation. Trends Mol Med 7(5):213-221
142. Carter WG, Wayner EA (1988) Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263(9):4193-4201
143. Yagi M, Sato N, Mitsui Y, Gotoh M, Hamada T, Nagata K (2010) Hyaluronan modulates proliferation and migration of rabbit fi broblasts derived from fl exor tendon epitenon and endotenon. J Hand Surg [Am] 35(5):791-796
144. Ansorge HL, Beredjiklian PK, Soslowsky LJ (2009) CD44 defi ciency improves healing tendon mechanics and increases matrix and cytokine expression in a mouse patellar tendon injury model. J Orthop Res 27(10):1386-1391
145. Chen S, Sun M, Meng X, Iozzo RV, Kao WW, Birk DE (2011) Pathophysiological mechanisms of autosomal dominant congenital stromal corneal dystrophy: C-Terminal-Truncated decorin results in abnormal matrix assembly and altered expression of small leucine-rich proteoglycans. Am J Pathol 179(5):2409-2419
146. Valjent E, Bertran-Gonzalez J, Herve D, Fisone G, Girault JA (2009) Looking BAC at striatal signaling: Cell-specifi c analysis in new transgenic mice. Trends Neurosci 32(10):538-547
147. Logan M, Martin JF, Nagy A, Lobe C, Olson EN, Tabin CJ (2002) Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 33(2):77-80
148. Seo HS, Serra R (2007) Deletion of Tgfbr2 in Prx1- cre expressing mesenchyme results in Defects in Development of the long bones and joints. Dev Biol 310(2):304-316
149. Rinkevich Y, Lindau P, Ueno H, Longaker MT, Weissman IL (2011) Germ-layer and lineage- restricted stem/progenitors regenerate the mouse digit tip. Nature 476(7361):409-413
150. Soeda T, Deng JM, de Crombrugghe B, Behringer RR, Nakamura T, Akiyama H (2010) Sox9- expressing precursors are the cellular origin of the cruciate ligament of the knee joint and the limb tendons. Genesis 48(11):635-644
151. Zha L, Hou N, Wang J, Yang G, Gao Y, Chen L, Yang X (2008) Collagen1alpha1 promoter drives the expression of Cre recombinase in osteoblasts of transgenic mice. J Genet Genomics 35(9):525-530
152. Zhu M, Chen M, Lichtler AC, O'Keefe RJ, Chen D (2008) Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1- CreER(T2) transgenic mice. Osteoarthr Cartil 16(1):129-130
153. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H (1996) Doxycyclinemediated quantitative and tissue-specifi c control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 93(20):10933-10938